This again supports that the underlying neurodegenerative mechanisms of prion diseases can also occur in the asymptomatic stages of the disease and, although NfL is an unspecific marker of axonal damage, it could be useful in the identification of preclinical prion cases combined with other proteins, such as tau and 14-3-3. This evidence concerns the gene YWHAQ and prion disease.